BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33975420)

  • 1. Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn's disease.
    Bamba S; Inatomi O; Nishida A; Ohno M; Imai T; Takahashi K; Naito Y; Iwamoto J; Honda A; Inohara N; Andoh A
    Intest Res; 2022 Jul; 20(3):370-380. PubMed ID: 33975420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
    Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
    FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma bile acids in association with Crohn's disease.
    Kiasat A; Prast-Nielsen S; Rautiainen S; Engstrand L; Andersson F; Lindberg J; Schuppe-Koistinen I; Löf Granström A; Gustafsson UO
    Scand J Gastroenterol; 2024 Jun; 59(6):674-682. PubMed ID: 38505982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
    Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
    J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn's disease.
    Handa O; Miura H; Gu T; Osawa M; Matsumoto H; Umegaki E; Inoue R; Naito Y; Shiotani A
    Redox Rep; 2023 Dec; 28(1):2241615. PubMed ID: 37530134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Specific Signatures of the Oral Cavity, Sputum, and Ileum Microbiota in Patients With Crohn's Disease.
    Xia K; Gao R; Wu X; Sun J; Wan J; Wu T; Fichna J; Yin L; Chen C
    Front Cell Infect Microbiol; 2022; 12():864944. PubMed ID: 35493739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn's disease.
    Han B; Tang D; Lv X; Fan J; Li S; Zhu H; Zhang J; Xu S; Xu X; Huang Z; Huang Z; Lin G; Zhan L; Lv X
    Gut Microbes; 2024; 16(1):2310894. PubMed ID: 38312103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosa-Associated Ileal Microbiota in New-Onset Pediatric Crohn's Disease.
    Assa A; Butcher J; Li J; Elkadri A; Sherman PM; Muise AM; Stintzi A; Mack D
    Inflamm Bowel Dis; 2016 Jul; 22(7):1533-9. PubMed ID: 27271491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease recurrence updates: first surgery
    Russo E; Cinci L; Di Gloria L; Baldi S; D'Ambrosio M; Nannini G; Bigagli E; Curini L; Pallecchi M; Andrea Arcese D; Scaringi S; Malentacchi C; Bartolucci G; Ramazzotti M; Luceri C; Amedei A; Giudici F
    Front Immunol; 2022; 13():886468. PubMed ID: 35967326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.
    He C; Wang H; Yu C; Peng C; Shu X; Liao W; Zhu Z
    Front Bioeng Biotechnol; 2021; 9():673691. PubMed ID: 34295880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.
    Mondot S; Lepage P; Seksik P; Allez M; Tréton X; Bouhnik Y; Colombel JF; Leclerc M; Pochart P; Doré J; Marteau P;
    Gut; 2016 Jun; 65(6):954-62. PubMed ID: 26628508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features of the gut prokaryotic virome of Japanese patients with Crohn's disease.
    Imai T; Inoue R; Nishida A; Yokota Y; Morishima S; Kawahara M; Kusada H; Tamaki H; Andoh A
    J Gastroenterol; 2022 Aug; 57(8):559-570. PubMed ID: 35689701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease.
    Russo E; Giudici F; Ricci F; Scaringi S; Nannini G; Ficari F; Luceri C; Niccolai E; Baldi S; D'Ambrosio M; Ramazzotti M; Amedei A
    J Crohns Colitis; 2021 Sep; 15(9):1500-1516. PubMed ID: 33611347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.